← Back to Clinical Trials
Recruiting NCT07826260

NCT07826260 Immediate Effect of Lumbar Mobilization on Paraspinal Muscle Stiffness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07826260
Status Recruiting
Phase —
Sponsor University of Primorska
Condition Muscle Stiffness
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2026-09-30
Primary Completion 2026-11-26

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Maitland Grade III++ Central Posteroanterior MobilizationSham Lumbar Mobilization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2026-09-30 with a primary completion date of 2026-11-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled crossover study will investigate the immediate effect of central posteroanterior lumbar mobilization on the intrinsic stiffness of the erector spinae and multifidus muscles in healthy adults without low back pain. Twenty-four participants will complete two experimental visits in randomized order. During one visit, participants will receive Maitland Grade III++ central posteroanterior mobilization at the L4 vertebral level, while during the other visit they will receive a sham mobilization condition involving gentle rhythmic pressure. Muscle stiffness will be assessed using shear wave elastography immediately before and after each intervention.

Eligibility Criteria

Inclusion Criteria: * Men and women aged 21 to 38 years. * Resident of the Republic of Slovenia. * No current low back pain. * No contraindications to lumbar manual mobilization. * Ability to assume and maintain the required prone testing position. * Provision of written informed consent. Exclusion Criteria: * Current low back pain. * Spondylolisthesis. * Severe osteoporosis. * Spinal stenosis. * Lumboischialgia or other significant structural spinal deformity. * Fibromyalgia. * Recent spinal surgery or lumbar spinal fixation. * Cauda equina syndrome. * Nerve root compression associated with neurological deficits. * Malignancy. * Recent relevant trauma. * Joint instability. * Active rheumatoid arthritis. * Acute local or systemic infection. * Long-term local corticosteroid use. * Inability to assume or maintain the required testing position.

Contact & Investigator

Central Contact

Žiga Kozinc, PhD

✉ ziga.kozinc@s2p.si

📞 040161503

Frequently Asked Questions

Who can join the NCT07826260 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Muscle Stiffness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07826260 currently recruiting?

Yes, NCT07826260 is actively recruiting participants. Contact the research team at ziga.kozinc@s2p.si for enrollment information.

Where is the NCT07826260 trial being conducted?

This trial is being conducted at Izola, Slovenia.

Who is sponsoring the NCT07826260 clinical trial?

NCT07826260 is sponsored by University of Primorska. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology